Advitech Inc. (TSX VENTURE:AVI) today announced that it has reached an agreement in principle, setting forth the proposed scope of a marketing and distribution agreement for Dermylex™ with Enbio-Life Biotechnology & Medical Company Ltd, (“Enbio-Life”), a subsidiary of Yusheng Pharma. Enbio-Life is a Taiwanese company, which markets nutraceutical products in Taiwan, China and other Asian countries. This agreement is for the Taiwanese market and Enbio-Life has an option for the market in China as well.
